Online citations, reference lists, and bibliographies.
← Back to Search

Mucoadhesive Liposomes As New Formulation For Vaginal Delivery Of Curcumin.

K. Berginc, Sabina Suljaković, N. Škalko-Basnet, A. Kristl
Published 2014 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Local delivery to the affected area represents the optimal means by which advantageous pharmacological properties of curcumin may be fully exploited as currently, due to the biopharmaceutical limitations associated with this polyphenol, its full beneficial effects remain limited. Curcumin-containing liposomes coated with bioadhesive polymers of natural and synthetic origin (chitosan and Carbopol) were evaluated in vitro. For these purposes, an in vitro model of vaginal mucus was developed allowing the monitoring of curcumin permeability in the conditions mimicking vaginal environment. The model was optimized by varying the amounts of glycoproteins, as compared to the permeabilities determined through isolated bovine mucus. The strength of bioadhesion was evaluated using the isolated bovine mucosa. Both curcumin solution and non-coated curcumin liposomes served as controls. Bioadhesive polymers enabled significantly higher (p<0.05) curcumin permeability through the artificial and isolated bovine mucus compared to the controls. Polymer coating of liposomes resulted in an increase in their bioadhesiveness. Mucoadhesive liposomes can be considered as potential novel drug delivery systems intended for vaginal administration of curcumin.
This paper references
10.5455/SPATULA.20120508105441
and #8216;Curcumin and #8217; A Therapeutic Approach: A Review
V. Anand (2012)
10.1002/jps.22785
Liposomal delivery system enhances anti-inflammatory properties of curcumin.
Purusotam Basnet (2012)
10.1016/S0142-9612(00)00134-4
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa.
S. Şenel (2000)
10.1016/S0169-409X(01)00115-6
Drug transfer through mucus.
K. Khanvilkar (2001)
10.1016/j.ejps.2013.04.035
Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?
Željka Vanić (2013)
10.1007/BF00988838
Cyclical changes in volatile acidic metabolites of human vaginal secretions and their relation to ovulation
G. Preti (2004)
10.1016/j.ygyno.2012.12.005
A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells.
P. R. Debata (2013)
10.3390/molecules16064567
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Purusotam Basnet (2011)
10.3892/IJO.32.5.1119
Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.
R. Thangapazham (2008)
10.1016/0304-4165(80)90009-4
Composition and functioin of human cervical mucus.
D. Wolf (1980)
10.2174/157488510791065067
Novel Vaginal Drug Delivery Systems: A Review
Umme Hani (2010)
10.1002/ijc.24336
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
N. Narayanan (2009)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.18433/J3HP41
Strategies to prolong the intravaginal residence time of drug delivery systems.
E. Baloğlu (2009)
10.1208/s12249-012-9837-9
Development and Evaluation of an In Vitro Vaginal Model for Assessment of Drug’s Biopharmaceutical Properties: Curcumin
K. Berginc (2012)
10.3109/08982104.2010.550265
Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity
M. D. di Cagno (2011)
10.1158/1535-7163.MCT-06-0556
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
L. Li (2007)
10.1016/S0169-409X(01)00180-6
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
10.1002/biof.1041
Molecular mechanisms of curcumin action: Gene expression
S. Shishodia (2013)
10.3109/03639049709148498
Mucoadhesive Drug Delivery Systems
A. Ahuja (1997)
Physiological barriers to the oral delivery of curcumin.
K. Berginc (2012)
10.1016/j.ijpharm.2008.09.009
An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
C. Chen (2009)
10.1042/BJ2110013
Isolation and characterization of human cervical-mucus glycoproteins.
I. Carlstedt (1983)
10.1016/j.drudis.2011.09.015
Liposomal drug formulations in cancer therapy: 15 years along the road.
M. Slingerland (2012)
10.1615/CRITREVTHERDRUGCARRIERSYST.V25.I3.10
Mucoadhesion and the gastrointestinal tract.
F. J. O. Varum (2008)
10.3109/03639045.2010.523425
Mucoadhesive liposomal delivery systems: the choice of coating material
P. R. Karn (2011)
10.3109/03639045.2011.623355
Vaginal mucoadhesive drug delivery systems
Raphaela Regina de Araújo Pereira (2012)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
‘Curcumin’ A Therapeutic Approach: A Review -
V. Anand (2012)
10.1081/DDC-100107323
Comparative Permeability of Some Acyclovir Derivatives Through Native Mucus and Crude Mucin Dispersions
I. Legen (2001)
10.1016/J.ADDR.2005.07.006
Comparison of the mucoadhesive properties of various polymers.
V. Grabovac (2005)
10.1016/J.IJPHARM.2003.12.018
Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
G. Di Colo (2004)
10.1016/s0015-0282(16)44952-6
Human cervical mucus and its mucous glycoprotein during the menstrual cycle.
R. van Kooij (1980)
10.1002/biof.1042
Curcumin uptake and metabolism
M. Metzler (2013)



This paper is referenced by
10.1016/j.ijpharm.2015.12.030
An in vitro study of mucoadhesion and biocompatibility of polymer coated liposomes on HT29-MTX mucus-producing cells.
Małgorzata Adamczak (2016)
10.1016/j.ejps.2017.09.039
Mucoadhesive maleimide‐functionalised liposomes for drug delivery to urinary bladder
Daulet B Kaldybekov (2018)
10.1016/j.ejpb.2015.01.019
Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application.
T. Furst (2015)
10.1016/j.ijpharm.2015.04.052
Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins.
Heba Abd El Azim (2015)
10.1016/j.addr.2015.02.001
Mucoadhesive and thermogelling systems for vaginal drug delivery.
C. Caramella (2015)
10.3390/pharmaceutics12060568
The Vaginal-PVPA: A Vaginal Mucosa-Mimicking In Vitro Permeation Tool for Evaluation of Mucoadhesive Formulations
Margherita Falavigna (2020)
10.5530/RJPS.2014.4.3
A Review on Vaginal Drug Delivery System
Arshad Bashir Khan (2015)
Development of biomimetic phospholipid vesicle-based permeation assays (PVPA) as screening tool in drug development
Elenaz Naderkhani (2015)
A REVIEW ON NANOPARTICULATE MUCOADHESIVE SYSTEM
Gouri Shankar (2017)
10.1021/acsami.5b01786
Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
S. Patra (2015)
10.1016/S1773-2247(14)50085-8
Mucosal nanosystems for improved topical drug delivery: vaginal route of administration
Željka Vanić (2014)
10.1016/B978-0-323-46142-9.00012-8
Nanostructured therapeutic systems with bioadhesive and thermoresponsive properties
M. Bruschi (2017)
10.1016/j.ijpharm.2014.06.034
Hybrid liposomal PEGylated calix[4]arene systems as drug delivery platforms for curcumin.
Elena Drakalska (2014)
10.1002/9781119640240.ch11
Vaginal Bioadhesive Drug Delivery Systems and Their Applications
Anju Sharma (2020)
10.3390/md15030064
Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes
Toril Andersen (2017)
10.1016/j.jconrel.2016.02.024
Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications.
Weize Li (2016)
10.1016/j.ejps.2015.07.005
Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems.
Ivelina Jelezova (2015)
10.1007/978-3-319-70299-5_8
Nanoformulations for Vaginal Therapy
Željka Vanić (2017)
10.1016/B978-0-12-809717-5.00012-9
Bioadhesive Polymers for Targeted Drug Delivery
Lalit Kumar (2017)
10.22270/ujpr.v2i6.rw3
AN EXHAUSTIVE STATISTIC ON CURRENT MUCOADHESIVE INTRAVAGINAL DRUG DELIVERY METHODOLOGIES
Abhijeet Ojha (2018)
10.3390/ijms19061549
Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art
G. Leyva-Gómez (2018)
10.2174/1381612821666150820100653#STHASH.V2XXPZFF.DPUF
Polysaccharide Based Formulations for Mucosal Drug Delivery: A Review.
J. Boateng (2015)
10.2174/1872211313666190215141507
Nanocarriers for vaginal drug delivery.
Z. Iqbal (2019)
10.3390/md13095976
Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation
María-Pilar Sánchez-Sánchez (2015)
10.1016/j.colsurfb.2016.09.049
Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier.
Jakarwan Yostawonkul (2017)
10.35120/kij2802461a
THE BENEFITS OF CURCUMIN IN VARIOUS DISEASES AND THE EXTENSION OF ITS APPLICATION THROUGH VARIOUS TECHNOLOGICAL APPROACHES
Daniel Argilashki (2018)
10.1016/j.jconrel.2016.11.031
Urothelium‐adherent, ion‐triggered liposome‐in‐gel system as a platform for intravesical drug delivery
Shruti Guhasarkar (2017)
10.1016/j.molliq.2020.112969
The effect of carbomer 934P and different vegetable oils on physical stability, mechanical and rheological properties of emulsion-based systems containing propolis
Rafaela Said dos Santos (2020)
10.1016/j.ejps.2018.06.030
Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation
M. J. de Jesús Valle (2018)
10.1002/9781119640240.ch3
In Vitro , Ex Vivo and In Vivo Methods for Characterization of Bioadhesiveness of Drug Delivery Systems
Ljiljana Djekic (2020)
10.1016/j.ijpharm.2017.12.038
Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.
Margherita Falavigna (2018)
10.1016/j.ijpharm.2014.06.016
Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect.
May Wenche Jøraholmen (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar